Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Schuster

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Annals of Hematology|August 12, 2016
Selective expansion of regulatory T cells during lenalidomide treatment of myelodysplastic syndrome with isolated deletion 5qEkaterina Balaian, Claudia Schuster, Claudia Schönefeldt, et al.
BMC Genomics|November 2, 2007
The full-ORF clone resource of the German cDNA ConsortiumStephanie Bechtel, Heiko Rosenfelder, Anny Duda, et al.
British Journal of Haematology|October 8, 2016
Mammalian-target of rapamycin inhibition with temsirolimus in myelodysplastic syndromes (MDS) patients is associated with considerable toxicity: results of the temsirolimus pilot trial by the German MDS Study Group (D-MDS)Martin Wermke, Claudia Schuster, Florian Nolte, et al.
Nature Genetics|February 27, 2007
Mapping autism risk loci using genetic linkage and chromosomal rearrangements, Peter Szatmari, Andrew D Paterson, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Annals of Hematology|August 12, 2016
Selective expansion of regulatory T cells during lenalidomide treatment of myelodysplastic syndrome with isolated deletion 5qEkaterina Balaian, Claudia Schuster, Claudia Schönefeldt, et al.
BMC Genomics|November 2, 2007
The full-ORF clone resource of the German cDNA ConsortiumStephanie Bechtel, Heiko Rosenfelder, Anny Duda, et al.
British Journal of Haematology|October 8, 2016
Mammalian-target of rapamycin inhibition with temsirolimus in myelodysplastic syndromes (MDS) patients is associated with considerable toxicity: results of the temsirolimus pilot trial by the German MDS Study Group (D-MDS)Martin Wermke, Claudia Schuster, Florian Nolte, et al.
Nature Genetics|February 27, 2007
Mapping autism risk loci using genetic linkage and chromosomal rearrangements, Peter Szatmari, Andrew D Paterson, et al.
Pageof 2